Dexcom
Hector Xiao is an experienced professional in analytical science, currently serving as the Head of Analytical Science at Dexcom since May 2023. Prior to this role, Hector was the Manager of Analytical, Operation & Supply at Arcturus Therapeutics, overseeing analytical support for CRO/CDMO activities related to lipid nanoparticles and managing a team of seven members. Hector's career includes notable positions at Dexcom as a Senior Analytical Scientist, and at HP as an Analytical Chemist, focusing on chemical characterization methods for various printing technologies. Earlier experience includes roles at Bayer, Nexgen Pharma, and U.S. Army Reserve, along with a strong academic background with a Master of Science in Analytical Chemistry from Ohio University, where teaching and research responsibilities were also undertaken.
This person is not in any teams
Dexcom
43 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.